1. Home
  2. SCPH vs ATNI Comparison

SCPH vs ATNI Comparison

Compare SCPH & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • ATNI
  • Stock Information
  • Founded
  • SCPH 2013
  • ATNI 1987
  • Country
  • SCPH United States
  • ATNI United States
  • Employees
  • SCPH N/A
  • ATNI N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • ATNI Telecommunications Equipment
  • Sector
  • SCPH Health Care
  • ATNI Telecommunications
  • Exchange
  • SCPH Nasdaq
  • ATNI Nasdaq
  • Market Cap
  • SCPH 299.0M
  • ATNI 254.3M
  • IPO Year
  • SCPH 2017
  • ATNI 1991
  • Fundamental
  • Price
  • SCPH $5.63
  • ATNI $15.57
  • Analyst Decision
  • SCPH Buy
  • ATNI Strong Buy
  • Analyst Count
  • SCPH 3
  • ATNI 1
  • Target Price
  • SCPH $12.00
  • ATNI $30.00
  • AVG Volume (30 Days)
  • SCPH 2.3M
  • ATNI 34.6K
  • Earning Date
  • SCPH 11-12-2025
  • ATNI 10-28-2025
  • Dividend Yield
  • SCPH N/A
  • ATNI 7.07%
  • EPS Growth
  • SCPH N/A
  • ATNI N/A
  • EPS
  • SCPH N/A
  • ATNI N/A
  • Revenue
  • SCPH $49,969,000.00
  • ATNI $719,593,000.00
  • Revenue This Year
  • SCPH $108.95
  • ATNI $1.65
  • Revenue Next Year
  • SCPH $78.30
  • ATNI $1.59
  • P/E Ratio
  • SCPH N/A
  • ATNI N/A
  • Revenue Growth
  • SCPH 107.79
  • ATNI N/A
  • 52 Week Low
  • SCPH $1.94
  • ATNI $13.76
  • 52 Week High
  • SCPH $6.28
  • ATNI $33.72
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 64.37
  • ATNI 45.45
  • Support Level
  • SCPH $4.33
  • ATNI $15.00
  • Resistance Level
  • SCPH $5.62
  • ATNI $17.54
  • Average True Range (ATR)
  • SCPH 0.05
  • ATNI 1.00
  • MACD
  • SCPH 0.01
  • ATNI 0.01
  • Stochastic Oscillator
  • SCPH 93.75
  • ATNI 22.44

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About ATNI ATN International Inc.

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.

Share on Social Networks: